(PDF) Susceptibilities of 45 Clinical Isolates of Proteus

Susceptibilities of 45 Clinical Isolates of Proteus Penneri.

Antimicrobial Agents and Chemotherapy - United States

doi 10.1128/aac.26.3.419

Full Text

Abstract

Available in full text

Categories

Infectious Diseases

Date

September 1, 1984

Authors

Publisher

American Society for Microbiology

Related search

Antimicrobial Susceptibilities of Clinical Isolates of Acinetobacter Baumannii From Singapore.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Characterization of Epitope Specificity of Proteus Penneri 7 Lipopolysaccharide Core Region.

Acta Biochimica Polonica

Molecular Biology

English

Flow Cytometric Determination of Ganciclovir Susceptibilities of Human Cytomegalovirus Clinical Isolates

Journal of Clinical Microbiology

English

Susceptibilities of Recent Clinical Isolates of Rickettsia Tsutsugamushi to Chemotherapeutic Agents in Vitro

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases

English

Clinical Isolates of Streptococcus Pneumoniae With Different Susceptibilities to Ceftriaxone and Cefotaxime

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Phenotypic Description and Antimicrobial Susceptibilities of Aerococcus Sanguinicola Isolates From Human Clinical Samples

Journal of Clinical Microbiology

English

Comparison of PCR-based Molecular Markers for the Characterization of Proteus Mirabilis Clinical Isolates

Brazilian Journal of Infectious Diseases

Infectious Diseases

English

In Vitro Susceptibilities of Clinical Isolates of Carbapenemase-Producing Enterobacteriaceae to Fosfomycin and Tigecycline

Clinical Microbiology and Infection

Infectious Diseases

English

Susceptibilities of Clinical and Laboratory Isolates of Blastomyces Dermatitidis to Ketoconazole, Itraconazole, and Fluconazole

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English